FDA Approves New Medication for Chronic Weight Management

The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a reduced calorie diet and increased physical activity.

Related Keywords

United States ,American ,Eli Lilly ,John Sharretts ,Human Services ,Drug Administration ,Division Of Diabetes ,Us Department Of Health ,For Immediate Release ,Lipid Disorders ,Drug Evaluation ,Multiple Endocrine Neoplasia ,Priority Review ,Fast Track ,